Neri Flavia, Maroni Lorenzo, Ravaioli Matteo
Unit of Kidney and Pancreas Transplantation, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.
General Surgery and Transplant Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Transl Cancer Res. 2019 Apr;8(Suppl 3):S245-S260. doi: 10.21037/tcr.2018.12.28.
Hepatocellular carcinoma (HCC) is the most common liver tumour and represents a significant health burden. The different characteristics of the disease in the various parts of the world, as much as economic and social features, explain only partially the great diversity in the treatment options offered to patients in different countries. The most apparent contrast in term of tumour management is between the western and eastern world. Striking differences involve not only the attitude towards indications for liver transplantation or liver resection but also the surgical techniques adopted. Although remarkable signs of progress have been achieved in surgical and pharmacological fields, univocal guidelines are yet lacking, preventing effective comparisons between retrospective studies and clinical trials. This review aims to analyse and compare some of the most relevant and essential traits of the eastern and western therapeutic strategy against HCC.
肝细胞癌(HCC)是最常见的肝脏肿瘤,也是一项重大的健康负担。世界各地该疾病的不同特征,以及经济和社会特征,只能部分解释不同国家为患者提供的治疗选择存在巨大差异的原因。在肿瘤治疗方面,最明显的对比存在于西方和东方世界之间。显著差异不仅涉及对肝移植或肝切除适应症的态度,还包括所采用的手术技术。尽管在外科和药理学领域已经取得了显著的进展迹象,但仍缺乏统一的指南,这使得回顾性研究和临床试验之间无法进行有效的比较。本综述旨在分析和比较东西方针对HCC的治疗策略中一些最相关和关键的特征。